课题基金 / 基金详情

High Throughput Profiling of Plant Extracts Using Engineered Heart Tissues

High Throughput Profiling of Plant Extracts Using Engineered Heart Tissues
使用工程心脏组织对植物提取物进行高通量分析
批准号:
7222028
负责人:
Tetsuro Wakatsuki
金额:
$9.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-30 至 2008-08-31

项目摘要

项目成果

Tetsuro Wakatsuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project will optimize an existing innovative method for performing high-throughput screening assays using engineered tissues that mimic the myocardium and a novel, screening instrument that can rapidly measure the mechanical properties of those tissues. Our engineered tissues significantly reduce the need for whole animal testing. In the proposed research, we will focus on refining our heart tissue model growing in a 96-well format. We will produce samples with identical physiological properties that have Z-factors >0.5 in high-throughput screening assays using our screening instrument. We will perform a blind screen using known compounds with known effects on myocardium to evaluate our measure of success. Further, we will test 3 drugs, known to affect cardiovascular functions, using an established toxicity assay and our engineered tissue assay system and correlate the results. Our strategic business partner, Gilson, Inc. (Middleton, WI), which has more than 50 years of business development experience in the life science industry, will collaborate with us on the engineering efforts to improve our screening instrument and develop consumable products with our engineered tissues. After confirming the usefulness and reproducibility of the assay, we will profile a small library of plant extracts from the Philippines. The full library of extracts (16,000 samples) is available only to scientists at the Medical College of Wisconsin who collaborate on this project. NCI has previously screened and ranked the extracts in this library for cytotoxicity on HL60 cells. The sub-library consists of 1,045 extracts that showed the lowest toxicity in the NCI study. We will identify "hit" extracts by their ability to alter 2 important parameters of myocardial contraction measured by our tissue assay system. In Phase II studies, we will focus on characterizing the active components in any extracts that changed myocardial contraction in our assay and screening and profiling the entire library. The ultimate goal of this project is to rapidly and cost-effectively identify an herbal remedy, or compounds from natural products, that could treat cardiovascular diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3791/52755
发表时间: 2015-05-14
期刊: Journal of visualized experiments : JoVE
影响因子: --
作者: [Conway MK, Gerger MJ, Balay EE, O'Connell R, Hanson S, Daily NJ, Wakatsuki T]
通讯作者: Wakatsuki T
Diagnostic Tools for Targeted Heart Failure Treatments
  • 批准号:
    10546035
  • 项目类别:
  • 资助金额:
    $49.37万
  • 财政年份:
    2022
  • 负责人:
    Tetsuro Wakatsuki
  • 依托单位:
HLS-Cardiac Safety AI Trained Human Heart and Micro Heart Model
  • 批准号:
    9764845
  • 项目类别:
  • 资助金额:
    $88.17万
  • 财政年份:
    2019
  • 负责人:
    Tetsuro Wakatsuki
  • 依托单位:
An Aging Heart Model for Drug Discovery
  • 批准号:
    9331414
  • 项目类别:
  • 资助金额:
    $17.64万
  • 财政年份:
    2016
  • 负责人:
    Tetsuro Wakatsuki
  • 依托单位:
Engineered Tissue Based Phenotypic Screening of Mixture based Libraries
  • 批准号:
    9145632
  • 项目类别:
  • 资助金额:
    $35.0万
  • 财政年份:
    2015
  • 负责人:
    Tetsuro Wakatsuki
  • 依托单位:
国内基金
海外基金
亚麻LuMOD1(mosaic death 1)基因调控种子大小的分子机理研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    江海霞
  • 依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
  • 批准号:
    82370923
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张文杰
  • 依托单位:
METTL7B通过m6A甲基化GPX4抑制非小细胞肺癌细胞铁死亡的机制研究
  • 批准号:
    32100609
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    宋惠彬
  • 依托单位:
褪黑素促进MCL-1抑制剂诱导白血病细胞凋亡的分子机制研究